Machine-Learning Approaches for Predicting the Need of Oxygen Therapy in Early-Stage COVID-19 in Japan: Multicenter Retrospective Observational Study.
COVID-19
PROBAST
TRIPOD
machine learning
medical triage
multicenter
prognostic model
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
12
2021
accepted:
27
01
2022
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Early prediction of oxygen therapy in patients with coronavirus disease 2019 (COVID-19) is vital for triage. Several machine-learning prognostic models for COVID-19 are currently available. However, external validation of these models has rarely been performed. Therefore, most reported predictive performance is optimistic and has a high risk of bias. This study aimed to develop and validate a model that predicts oxygen therapy needs in the early stages of COVID-19 using a sizable multicenter dataset. This multicenter retrospective study included consecutive COVID-19 hospitalized patients confirmed by a reverse transcription chain reaction in 11 medical institutions in Fukui, Japan. We developed and validated seven machine-learning models (e.g., penalized logistic regression model) using routinely collected data (e.g., demographics, simple blood test). The primary outcome was the need for oxygen therapy (≥1 L/min or SpO Of the 396 patients with COVID-19 for the model development, 102 patients (26%) required oxygen therapy during hospitalization. For internal validation, machine-learning models, except for the Machine-learning models demonstrated a more significant performance in predicting the need for oxygen therapy in the early stages of COVID-19.
Sections du résumé
Background
UNASSIGNED
Early prediction of oxygen therapy in patients with coronavirus disease 2019 (COVID-19) is vital for triage. Several machine-learning prognostic models for COVID-19 are currently available. However, external validation of these models has rarely been performed. Therefore, most reported predictive performance is optimistic and has a high risk of bias. This study aimed to develop and validate a model that predicts oxygen therapy needs in the early stages of COVID-19 using a sizable multicenter dataset.
Methods
UNASSIGNED
This multicenter retrospective study included consecutive COVID-19 hospitalized patients confirmed by a reverse transcription chain reaction in 11 medical institutions in Fukui, Japan. We developed and validated seven machine-learning models (e.g., penalized logistic regression model) using routinely collected data (e.g., demographics, simple blood test). The primary outcome was the need for oxygen therapy (≥1 L/min or SpO
Results
UNASSIGNED
Of the 396 patients with COVID-19 for the model development, 102 patients (26%) required oxygen therapy during hospitalization. For internal validation, machine-learning models, except for the
Conclusions
UNASSIGNED
Machine-learning models demonstrated a more significant performance in predicting the need for oxygen therapy in the early stages of COVID-19.
Identifiants
pubmed: 35280897
doi: 10.3389/fmed.2022.846525
pmc: PMC8904892
doi:
Types de publication
Journal Article
Langues
eng
Pagination
846525Informations de copyright
Copyright © 2022 Yamanaka, Morikawa, Azuma, Yamanaka, Shimada, Wada, Matano, Yamada, Yamamura and Hayashi.
Déclaration de conflit d'intérêts
KM was employed by Connect Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ. 2015 Jan 07;350:g7594
pubmed: 25569120
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
IEEE Trans Neural Netw. 1992;3(5):683-97
pubmed: 18276468
Lancet Infect Dis. 2020 Sep;20(9):1043-1050
pubmed: 32539988
Respirology. 2008 Sep;13(5):731-5
pubmed: 18713094
JCI Insight. 2020 Jul 9;5(13):
pubmed: 32544099
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Intern Med. 2006;45(7):419-28
pubmed: 16679695
Stat Med. 2016 Jan 30;35(2):214-26
pubmed: 26553135
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
BMJ Open. 2020 Sep 18;10(9):e041537
pubmed: 32948578
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Int J Health Care Qual Assur Inc Leadersh Health Serv. 2000;13(6-7):300-7
pubmed: 11484648
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
Evid Based Dent. 2020 Sep;21(3):84-86
pubmed: 32978532
J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):1947-58
pubmed: 14632445
Emerg Infect Dis. 2020 Oct;26(10):2346-2352
pubmed: 32568662
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Ann Intern Med. 2019 Jan 1;170(1):51-58
pubmed: 30596875
JMA J. 2021 Apr 15;4(2):148-162
pubmed: 33997449
Infect Dis Ther. 2021 Dec;10(4):2447-2463
pubmed: 34389970
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Intensive Care Med. 2020 May;46(5):833-836
pubmed: 32125458